Today's Top Gainer
| SYMBOL | CMP | Chg (%) |
|---|---|---|
Note:Top Gainer - Nifty 50 More
Cipla Ltd - Share Price
CIPLA
Financials
News & Updates
Cipla to declare Quarterly Result
Oct 15,2019 10:37 AM
On 6 November 2019
Market slips in early trade; Yes Bank, Cipla stocks drag Sep 30,2019
Cipla hits 52-week low after USFDA inspection Sep 30,2019
USFDA completes inspection at Cipla's Goa facility Sep 30,2019
Cipla receives 12 observations from USFDA inspection of its Goa facility Sep 28,2019
Booster dose for Cipla after launch of Daptomycin Sep 26,2019
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 401.50 | 43.76 | 95,853.43 | 763.37 | 0.69 | 3,020.49 | 95.21 |
| Divis Laboratories Ltd | 1,722.95 | 34.27 | 45,709.71 | 267.35 | 0.93 | 1,139.92 | 262.68 |
| Dr Reddys Laboratories Ltd | 2,727.40 | 29.99 | 44,872.64 | 548.10 | 0.74 | 2,497.60 | 766.66 |
| Cipla Ltd | 446.30 | 16.42 | 35,995.39 | 694.00 | 0.67 | 3,126.21 | 195.79 |
| Lupin Ltd | 726.50 | 19.63 | 33,147.38 | 445.93 | 0.68 | 2,878.91 | 378.16 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Summary & Reports
Cipla Ltd is one of the leading pharmaceutical companies in India. The company focuses on development of new formulations and has a wide range of pharmaceutical products. The product portfolio includes over 1,500 products across wide range of therapeutic categories.Cipla Ltd was incorporated in the year 1935 with the name Chemical, Industrial & Pharmaceutical Laboratories Ltd. Khwaja Abdul Hamied, the founder of Cipla gave the company ... More
Registered Office
Cipla House Peninsula Buss Par,Ganpatrao Kadam Mg Lower Parel,Mumbai, Maharashtra,400013
Tell. : +91-22-24826000
Website : http://www.cipla.com
Email : cosecretary@cipla.com
Registrar Office
Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA
Tell. : +91-40-67161500
Website : www.karvyfintech.com
Email : einward.ris@karvy.com
Reports by cipla-ltd
Latest Release by cipla-ltd
IIFLView
Buy - CIPLA
Reco. Price
513.00
Oct 17, 2019
Target Price
588.00
Target Returns:
14.62%
Result Express
Cipla Ltd's Q2FY19 consolidated net profit declines 10.8% yoy to Rs377.05cr: Misses Estimates
Oct 17, 2019 03:56 PM
The company’s consolidated revenue in the period stood at Rs4,011.9cr, down 1.73% yoy but up 1.85% qoq.
Shareholding Snapshot
Loading ...
| Jun - 2019 | |
|---|---|
| Promoter | - |
| Foreign | 21.71% |
| Indian | 14.96% |
| Total Promoter | 36.67% |
| Non Promoter | - |
| Institutions | 41.81% |
| Non-Institutions | 21.44% |
| Total Non-Promoter | 63.26% |
| Custodian | 0.07% |
| Total | 100% |
Corporate Action
Purpose
AGM
Exp. Date
16 Aug 2019
Annc. Date
22 Jul 2019
AGM:16.08.2019Notice of the 83rd Annual General Meeting (AGM) along with the copy of the Annual Repo... More
Purpose
Board Meeting
Exp. Date
07 Aug 2019
Annc. Date
15 Jul 2019
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on... More
Purpose
Dividend
Annc. Date
22 May 2019
Effective. Date
31 Jul 2019
Divi. Type
Final
Divi.(%)
150
Divi. Amt.
3
Inter alia, the Board of Directors recommended payment of dividend of Rs. 3 per equity share (face v... More
